Abstract: Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Abstract: The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt thereof, that inhibit phosphoinositide 3-kinase; methods of treating diseases or conditions, such as cancer, using the compounds; and pharmaceutical compositions containing the compounds.

Abstract: A plasma display panel (PDP) and a method for driving the PDP. An ON/OFF pattern of an externally-inputted image signal is checked to sense a sustained discharge occurring in discharge cells respectively corresponding to scan electrodes included in a particular one of multiple scan electrode groups over a predetermined time. A control operation is carried out in response to the sensing of the sustained discharge to allow a discharge to occur in discharge cells respectively corresponding to scan electrodes included in the scan electrode groups other than the particular scan electrode group.

Abstract: A power supply that is employable by a plasma display device for generating and supplying a plurality of voltages, the power supply including a first power source generating and supplying a first voltage, a transistor having a drain electrically coupled to the first power source, a first resistor having a first end coupled to the first power source and a second end electrically coupled to a gate of the transistor, a second resistor having a first end coupled to the second end of the first resistor and a second end electrically coupled to a second power source supplying a second voltage that is lower than the first voltage, and a capacitor having a first end coupled to a source of the transistor and a second end electrically coupled to the second power source. The coupling of the first end of the capacitor to the source of the transistor may form a third voltage supply node having the third voltage when the capacitor is charged.

Abstract: A method of driving a frame of plasma display device having a first electrode, a second electrode, and an address electrode, the method including gradually decreasing a voltage of the second electrode from a second voltage to a third voltage and, while decreasing the voltage of the second electrode, supplying a vertical synchronization pulse and applying a first voltage to the first electrode, after the voltage of the second electrode reaches the third voltage, gradually increasing the voltage of the second electrode from a fifth voltage to a sixth voltage while a fourth voltage is applied to the first electrode, and, after the voltage of the second electrode reaches the sixth voltage, gradually decreasing the voltage of the second electrode from an eighth voltage to a ninth voltage while a seventh voltage is applied to the first electrode.

Abstract: Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Abstract: Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Abstract: A method of expressing gray scales of a plasma panel display using the sum of weights assigned to subfields, including extracting a first gray scale arrangement including gray scale n using (k?1) subfields to gray scale m using k subfields from a second gray scale arrangement including gray scale 1 to gray scale m using k subfields between the 1st and the jth subfields when the number of subfields used for gray scale (i+1) is the same or greater than the number of subfields used for gray scale i, and generating a third gray scale arrangement including gray scales (n+p) to (m+p) by adding a weight p of the (j+1)th subfield to the first gray subfield arrangement including the gray scales n to m.

Abstract: In a plasma display device and a driving method thereof, a scan voltage is set to be lower than a reset minimum voltage in order to reduce an address discharge delay in an address period. In addition, in the address period, an address voltage and a scan voltage are set to be lower. In order to prevent misfiring in the address period, a voltage biasing a sustain electrode in the address period is set to be lower than a voltage biasing the sustain electrode in a falling period of a reset period.

Abstract: A method for driving a plasma display panel. The plasma display panel includes a plurality of Y electrodes, a plurality of X electrodes, and a plurality of address electrodes. The Y electrodes are divided into a plurality of groups according to an order for scanning the Y electrodes and scan voltages are established to be varied for different groups when the scan voltages are sequentially applied to the Y electrodes. A period for gradually reducing a voltage at the Y electrodes and a bias voltage at the X electrodes is further included when the scan voltages are applied to the first Y electrode of each group of Y electrodes.

Abstract: Selected amines are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Abstract: System for visualizing conductivity and current density distributions including a plurality of current injecting devices (100) for injecting currents into a measuring object; a measuring unit(200) for measuring a magnetic flux density due to the currents injected into a measuring object; an operating unit(300) for selecting one pair of the current injecting devices in succession so as to inject currents of different directions into the measuring object, and calculating directional components of an anisotropic conductivity inside of the measuring object on the basis of the measured magnetic flux density; and displaying means for visualizing an inside of the measuring object by using the calculated directional components of the anisotropic conductivity.

Abstract: The present invention comprises a new class of compounds capable of modulating the activity of PI3 kinase and, accordingly, useful for treatment of PI3 kinase mediated diseases, including melanomas, carcinomas and other cancer-related conditions. The compounds have a general Formula I wherein each of A1, A2, A3, A4, X, R1 and R2 are defined herein. The invention further comprises pharmaceutical compositions, methods for treatment of PI3 kinase mediated diseases, and intermediates and processes useful for the preparation of compounds of the invention.

Abstract: Disclosed is a method for enhancing blood vessels in angiography images. The method incorporates the use of linear directional features present in an image, extracted by a Directional Filter Bank, to obtain more precise Hessian analysis in noisy environment and thus can correctly reveal small and thin vessels. Also, the directional image decomposition helps to avoid junction suppression, which in turn, yields continuous vessel tree.

Abstract: A method and apparatus for driving a plasma display panel in which discharge cells are formed by first, second, and third electrodes, has a frame divided into a plurality of subfields, each of which includes a reset period, an address period, and a sustain period. In the reset period, a voltage at the first electrode is modified from a first voltage to a second voltage, the first electrode is floated; and the voltage at the first electrode is gradually reduced to a third voltage.

Abstract: A panel driving method in which a single TV field includes at least one reset period and at least one subfield and each of the at least one subfields includes an address period and a sustain period, includes supplying a variable reset pulse according to the length of a pause period in a previous or present TV field. A variable reset period is supplied according to the length of a pause period in a single TV field, so that a reset operation for preparing the address period is stably performed.

Abstract: Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Abstract: A Thin Film Transistor (TFT) reduces interconnection resistance of source/drain electrodes, prevents contamination from an active layer, reduces contact resistance between a pixel electrode and the source/drain electrodes, smoothly supplies hydrogen to the active layer and has high mobility, on-current characteristics, and threshold voltage characteristics. The TFT includes an active layer having a channel region and source/drain regions, a gate electrode supplying a signal to the channel region, source/drain electrodes respectively connected to the source/drain regions and including at least one of Ti, a Ti alloy, Ta, and a Ta alloy; and an insulating layer interposed between the source/drain electrodes and the active layer and including silicon nitride.

Abstract: Disclosed is a PDP driving method which may include generating subfield information that shows ON/OFF states of discharge cells from among a plurality of subfields from input image signals, generating address information that shows ON/OFF states of the discharge cells per subfield from the subfield data, counting the number of the discharge cells that are ON from among the discharge cells from the address data, and controlling a waveform applied during a reset period of a subsequent subfield.

Abstract: Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.